Related Experiment Video
Updated: Jun 8, 2026

10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
[Latent tuberculosis infection treatment. Current recommendations]
R Duarte1, M Villar, A Carvalho
1Centro Diagnóstico Pneumológico de Vila Nova de Gaia. raquelfduarte@gmail.com
Revista Portuguesa De Pneumologia
|October 8, 2010
Summary
Treating latent tuberculosis infection (LTBI) prevents active disease and community spread. Updated guidelines cover screening, testing with tuberculin skin test or interferon-gamma release assay (IGRA), and effective treatment regimens.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Context:
- Latent tuberculosis infection (LTBI) is a major risk factor for developing active tuberculosis (TB).
- Effective screening and treatment of LTBI are crucial for reducing TB transmission.
- Current diagnostic tools include symptom inquiry, chest radiography, tuberculin skin test (TST), and interferon-gamma release assay (IGRA).
Purpose:
- To provide updated recommendations for the diagnosis and treatment of latent tuberculosis infection.
- To guide healthcare providers on identifying individuals who require LTBI screening and treatment.
- To review current LTBI treatment regimens, considering efficacy and potential side effects.
Summary:
- This document outlines updated guidelines for managing latent tuberculosis infection (LTBI).
- It details the process of screening for LTBI, emphasizing the exclusion of active TB disease and the use of immune response tests like TST and IGRA.
- Recommendations cover patient selection for testing and a review of available treatment options, balancing effectiveness with safety.
Impact:
- Implementing these recommendations can significantly reduce the incidence of active TB.
- Improved LTBI management will contribute to decreased TB transmission within communities.
- Updated treatment guidelines aim to enhance patient outcomes and treatment adherence.
Related Concept Videos
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...